Cargando…

BAG-1 predicts patient outcome and tamoxifen responsiveness in ER-positive invasive ductal carcinoma of the breast

BAG-1 (bcl-2-associated athanogene) enhances oestrogen receptor (ER) function and may influence outcome and response to endocrine therapy in breast cancer. We determined relationships between BAG-1 expression, molecular phenotype, response to tamoxifen therapy and outcome in a cohort of breast cance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Millar, E K A, Anderson, L R, McNeil, C M, O'Toole, S A, Pinese, M, Crea, P, Morey, A L, Biankin, A V, Henshall, S M, Musgrove, E A, Sutherland, R L, Butt, A J
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2009
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2634679/ https://www.ncbi.nlm.nih.gov/pubmed/19066611 http://dx.doi.org/10.1038/sj.bjc.6604809

Ejemplares similares

Prediction of outcome of early ER+ breast cancer is improved using a biomarker panel, which includes Ki-67 and p53
por: Millar, E K A, et al.
Publicado: (2011)

Recruitment and Activation of Pancreatic Stellate Cells from the Bone Marrow in Pancreatic Cancer: A Model of Tumor-Host Interaction
por: Scarlett, Christopher J., et al.
Publicado: (2011)

Expression of LMO4 and outcome in pancreatic ductal adenocarcinoma
por: Murphy, N C, et al.
Publicado: (2008)

Purple Urine Bag Syndrome
por: Meekins, Pauline E., et al.
Publicado: (2012)

Co-overexpression of Bag-1 and heat shock protein 70 in human epidermal squamous cell carcinoma: Bag-1-mediated resistance to 5-fluorouracil-induced apoptosis
por: Wood, J, et al.
Publicado: (2011)

K-ras mutation in the endometrium of tamoxifen-treated breast cancer patients, with a comparison of tamoxifen and toremifene
por: Hachisuga, T, et al.
Publicado: (2005)

Identification of Functional Networks of Estrogen- and c-Myc-Responsive Genes and Their Relationship to Response to Tamoxifen Therapy in Breast Cancer
por: Musgrove, Elizabeth A., et al.
Publicado: (2008)

hERG1 channels drive tumour malignancy and may serve as prognostic factor in pancreatic ductal adenocarcinoma
por: Lastraioli, E, et al.
Publicado: (2015)

Immunohistochemical categorisation of ductal carcinoma in situ of the breast
por: Meijnen, P, et al.
Publicado: (2008)

CDK inhibitors as potential breast cancer therapeutics: new evidence for enhanced efficacy in ER(+ )disease
por: Sutherland, Robert L, et al.
Publicado: (2009)

Angiogenesis is associated with the onset of hyperplasia in human ductal breast disease
por: Bluff, J E, et al.
Publicado: (2009)

Retinoid Signaling in Pancreatic Cancer, Injury and Regeneration
por: Colvin, Emily K., et al.
Publicado: (2011)

Tumour epithelial vimentin expression and outcome of pancreatic ductal adenocarcinomas
por: Handra-Luca, A, et al.
Publicado: (2011)

Microvascular density and hypoxia-inducible factor pathway in pancreatic endocrine tumours: negative correlation of microvascular density and VEGF expression with tumour progression
por: Couvelard, A, et al.
Publicado: (2005)

Role of endoplasmic reticulum stress induction by the plant toxin, persin, in overcoming resistance to the apoptotic effects of tamoxifen in human breast cancer cells
por: McCloy, R A, et al.
Publicado: (2013)

Messina: A Novel Analysis Tool to Identify Biologically Relevant Molecules in Disease
por: Pinese, Mark, et al.
Publicado: (2009)

A distinct molecular profile associated with mucinous epithelial ovarian cancer
por: Heinzelmann-Schwarz, V A, et al.
Publicado: (2006)

Loss of GPER identifies new targets for therapy among a subgroup of ERα-positive endometrial cancer patients with poor outcome
por: Krakstad, C, et al.
Publicado: (2012)

Prognostic impact of syndecan-1 expression in invasive ductal breast carcinomas
por: Loussouarn, D, et al.
Publicado: (2008)

Oestrogen receptor β and neoadjuvant therapy with tamoxifen: prediction of response and effects of treatment
por: Miller, W R, et al.
Publicado: (2006)

Co-expression of KLK6 and KLK10 as prognostic factors for survival in pancreatic ductal adenocarcinoma
por: Rückert, F, et al.
Publicado: (2008)

The relationship between tumour budding, the tumour microenvironment and survival in patients with invasive ductal breast cancer
por: Gujam, F J A, et al.
Publicado: (2015)

Splenic Laceration and Pulmonary Contusion Injury From Bean Bag Weapon
por: Patel, Amar, et al.
Publicado: (2014)

The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro
por: O'Brien, P M, et al.
Publicado: (2008)

Tamoxifen resistance in early breast cancer: statistical modelling of tissue markers to improve risk prediction
por: Baneshi, M R, et al.
Publicado: (2010)

Tamoxifen Initiation After Ductal Carcinoma In Situ
por: Nichols, Hazel B., et al.
Publicado: (2016)

The relationship between the tumour stroma percentage, clinicopathological characteristics and outcome in patients with operable ductal breast cancer
por: Gujam, F J A, et al.
Publicado: (2014)

BAG-1 as a biomarker in early breast cancer prognosis: a systematic review with meta-analyses
por: Papadakis, E S, et al.
Publicado: (2017)

Changes in subcellular localisation of MI-ER1α, a novel oestrogen receptor-α interacting protein, is associated with breast cancer progression
por: McCarthy, P L, et al.
Publicado: (2008)

Antitumour and biological effects of letrozole and GnRH analogue as primary therapy in premenopausal women with ER and PgR positive locally advanced operable breast cancer
por: Torrisi, R, et al.
Publicado: (2007)

Tumour microenvironment of both early- and late-stage colorectal cancer is equally immunosuppressive
por: O'Toole, A, et al.
Publicado: (2014)

Combination of osteopontin and activated leukocyte cell adhesion molecule as potent prognostic discriminators in HER2- and ER-negative breast cancer
por: Ihnen, M, et al.
Publicado: (2010)

Oestrogen receptor-α contributes to the regulation of the hedgehog signalling pathway in ERα-positive gastric cancer
por: Kameda, C, et al.
Publicado: (2010)

Comparison of Visual and automated assessment of Ki-67 proliferative activity and their impact on outcome in primary operable invasive ductal breast cancer
por: Mohammed, Z M A, et al.
Publicado: (2012)

Proliferation marker securin identifies favourable outcome in invasive ductal breast cancer
por: Talvinen, K, et al.
Publicado: (2008)

The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapy
por: Tan, E Y, et al.
Publicado: (2009)

Immunological subtypes in breast cancer are prognostic for invasive ductal but not for invasive lobular breast carcinoma
por: Engels, C C, et al.
Publicado: (2014)

The relationship between lymphocyte subsets and clinico-pathological determinants of survival in patients with primary operable invasive ductal breast cancer
por: Mohammed, Z M A, et al.
Publicado: (2013)

Expression patterns of angiogenic and lymphangiogenic factors in ductal breast carcinoma in situ
por: Wülfing, P, et al.
Publicado: (2005)

Evaluation of ER, PgR, HER-2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer
por: Burcombe, R J, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_pr0m3jje41gnqinavsdkhlp7jt